Insomnia, Opioid Use Disorder
Conditions
Keywords
Mindfulness
Brief summary
This randomized, 35-day research study (n=20) explores the effects of a simplified mindfulness intervention in opioid use disorder patients stabilized on buprenorphine maintenance therapy (BMT), aiming to alleviate insomnia, monitor BMT dose, and decrease non-prescribed opioid use. Patients tap along with their breathing at bedtime and practice sleep hygiene; controls do sleep hygiene only. Adherence will be monitored by a smartphone application.
Detailed description
This research study is exploring the effects of a simplified mindfulness intervention in patients with opioid use disorder who are stabilized on buprenorphine maintenance therapy. This study aims to improve their sleep quality, monitor changes in buprenorphine dose, and decrease the frequency of non-prescribed opioids use. We will be enrolling a total of 20 patients who are above 18 years of age and have insomnia symptoms, opioid use disorder, and access to a smartphone. Patients will be asked to utilize a smartphone application which will allow us to monitor adherence; they will be asked to tap on the screen in time with their breathing before bedtime. Buprenorphine maintenance therapy is used to treat opioid use disorder (the buprenorphine will be prescribed by their healthcare provider as part of their standard clinical care and is not a research study intervention) by minimizing withdrawal symptoms, but symptoms of insomnia often persist. Symptoms of insomnia include difficulty falling/staying asleep, anxiety regarding sleep, or daytime sleepiness.
Interventions
BEHAVIORALSleep Hygiene
Once weekly coaching calls with advice on sleep hygiene
BEHAVIORALMindfulness
Once weekly coaching calls with advice on mindfulness
Sponsors
University of Pennsylvania
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Intervention model description
This will be conducted as a parallel, single-blinded pilot study for reducing insomnia among patients with opioid use disorder who are stabilized on buprenorphine maintenance therapy. All subjects will participate in some form of insomnia treatment over a fourteen-day period (either the mindfulness relaxation therapy with sleep hygiene or only sleep hygiene for controls). Consent and screening will occur on Day -7, and the sleep diary will be assigned for baseline measurement. Randomization and survey baseline measurements from eligible participants will occur on Day -1, and participants will be randomized into one of two arms: one arm consisting of only the sleep hygiene intervention and the other consisting of both the sleep hygiene and mindfulness interventions. On Day 28, two weeks post-intervention(s), surveys will be emailed to participants to track any changes in sleep quality, mean buprenorphine dose, and frequency of non-prescribed opioid use.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age greater than 18 2. Diagnosed with Opioid Use Disorder 3. Stable on Buprenorphine Maintenance Therapy for at least 4 weeks 4. At least 3 nights of greater than 30 minutes of sleep onset latency 5. Speak English above 6th grade level 6. Access to smart device
Exclusion criteria
1. Inability to communicate verbally 2. Involved in another insomnia study 3. Medical or other factors that in the opinion of the study research team would interfere with their ability to participate in the intervention
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Sleep Onset Latency | Day 28 | Time to fall asleep as derived from the Sleep Diary |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Non-Prescribed Opioid Use | Days -1, 7, 14, and 28 | Non-Prescribed Opioid Use Questionnaire |
| Daytime Cravings | Days 1 through 14 | Smartphone app usage during the day |
Countries
United States
Outcome results
None listed